Education Research Current Organisation and Cooperation NL
Login as
Prospective student Student Employee
Bachelor Master VU for Professionals
Exchange programme VU Graduate Winter School Honours programme VU-NT2 Semester in Amsterdam
PhD at VU Amsterdam Research highlights Prizes and distinctions
Research institutes Our scientists Research Impact Support Portal Creating impact
News Events calendar Energy in transition
Israël and Palestinian regions Women at the top Culture on campus
Practical matters Mission and core values Entrepreneurship on VU Campus
Organisation Partnerships Alumni University Library Working at VU Amsterdam
Sorry! De informatie die je zoekt, is enkel beschikbaar in het Engels.
This programme is saved in My Study Choice.
Something went wrong with processing the request.
Something went wrong with processing the request.

Biotech Booster funding for four VU innovations

13 November 2024
VU Amsterdam has secured Biotech Booster funding for three projects, that include a promising cancer treatment, innovation in biotechnology and a nutritional intervention for mental health. The researchers involved, together with the Biotech Booster business developers, will develop a solid business case for their innovations next.

All three research teams and are part of the VU AIMMS institute, Vrije Universiteit Amsterdam’s molecular research accelerator, What are the projects about and who are in the lead?

Advancing colorectal cancer treatment - Felix Paulussen

Felix Paulussen is working on project Ninetac, a new treatment for colorectal cancer which affects 1.9 million people annually and almost 1 million die as a consequence. Currently, surgery is the main treatment option, but Paulussen is developing a targeted therapy that focuses on a underlying cause at the level of gene activation, which could provide a more potent and selective drug.

Scaling up laboratory evolution of microorganisms - Jeroen Koendjbiharie

Researcher Jeroen Koendjbiharie is leading Evoducta—a groundbreaking project focused on scaling up laboratory evolution of microorganisms, which play a crucial role in biotechnology and food industries. Under the guidance of  Herwig Bachmann, Koendjbiharie and his team have developed a technology that significantly accelerates and enhances the cultivation of microorganisms compared to current methods.

Wellbeing and mental health through bolstering gut bacteria - Remco Kort

Recent studies have shown a connection between gut bacteria and mental health, mediated by the gut-brain axis. Taking a holistic approach to these findings, microbiome researcher Fleur van Eeden, part of Remco Kort's team, is developing the ‘Happy Bar’—a fermented oat bar containing bacteria that positively impact the gut microbiome and are specifically aimed at enhancing mental well-being.

Innovative biosensors for cancer diagnosis - Imran Avci

With around 1.8 million new cases per year, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer deaths globally. Imran Avci and team will further develop new patented detection technology and new sensing concepts, taking a significant step toward bringing innovative biosensors to market. 

About Biotech Booster

The Biotech Booster programme has been awarded a grant of € 250M from the National Growth Fund (Nationaal Groeifonds), with the aim for better conversion of biotechnological knowledge into business. In order to carry out the programme, various knowledge institutes from all over the Netherland have worked over the past year to apply for the programme.

Website Biotech Booster

Please contact IXA-GO for all your questions!

We are the knowledge transfer office of the VU and offer support for valorization.

info@ixa.nl

Quick links

Homepage Culture on campus VU Sports Centre Dashboard

Study

Academic calendar Study guide Timetable Canvas

Featured

VUfonds VU Magazine Ad Valvas

About VU

Contact us Working at VU Amsterdam Faculties Divisions
Privacy Disclaimer Veiligheid Webcolofon Cookies Webarchief

Copyright © 2024 - Vrije Universiteit Amsterdam